Publication
Article
Supplements and Featured Publications
Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin AmyloidosisVolume
Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis
The American Journal of Managed Care® hosted a scientific interchange titled “Value-Based Agreements in Rare Disease” on September 30, 2020. This publication highlights key discussion points and insights from this event.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
